Javier Rivera

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Neuropathic Pain

Ejection Fraction

Coronavirus Disease

Top Venues

Rheumatology international

BMC musculoskeletal disorders

Arthritis research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Trives-Folguera, Juan Molina Collada, Katerine López, Javier Rivera, Belén Serrano-Benavente, Ana M Anzola, Isabel Castrejon, José María Álvaro-Gracia, Julia Martinez-Barrio
Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study. Rheumatology international (2023)
Juan Molina Collada, Katerine López Gloria, Isabel Castrejon, Juan Carlos Nieto-González, Julia Martinez-Barrio, Ana M Anzola, Javier Rivera, José María Álvaro-Gracia
Impact of cardiovascular risk on the diagnostic accuracy of the ultrasound Halo Score for giant cell arteritis. Arthritis research & therapy 24 (1) (2022)
Javier Rivera, Tamara Rodríguez, Marta Pallarés, Isabel Castrejón, Teresa González, Laura Vallejo-Slocker, Juan Molina-Collada, Fernando Montero, Anna Arias, Miguel A Vallejo, Jose M Alvaro-Gracia, Antonio Collado
Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases. BMC musculoskeletal disorders 23 (1) (2022)
Martin Offenbächer, Niko Kohls, Thomas Ewert, Claudia Sigl, Robin Hieblinger, Loren L Toussaint, Fuschia M Sirois, Jameson K Hirsch, Miguel A Vallejo, Sybille Kramer, Javier Rivera, Gerold Stucki, Jorg Schelling, Andreas Winkelmann
Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective "real world" data analysis of fibromyalgia patients. Rheumatology international 41 (11) (2021)
Fernando Montero, Julia Martinez-Barrio, Belén Serrano-Benavente, Teresa González, Javier Rivera, Juan Molina Collada, Isabel Castrejon, José María Álvaro-Gracia
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatology international 40 (10) (2020)